Access1 Access2 Access3 Medication & Drugs Skin June 30, 2022 The Role of Dupilumab (Dupixent), an IL-4 Receptor Alpha Antagonist, in Atopic Dermatitis
Access1 Access2 Access3 Medication & Drugs Skin May 5, 2022 HSA Approves New JAK inhibitor Abrocitinib (Cibinqo) For The Treatment of Atopic Dermatitis
Access1 Access2 Access3 Medication & Drugs Skin February 17, 2022 HSA approves the first JAK inhibitor for moderate-to-severe atopic dermatitis: baricitinib (Olumiant)